Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
2.810
+0.120 (4.46%)
Nov 22, 2024, 4:00 PM EST - Market closed
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $180.51 million as of November 22, 2024. Its market cap has decreased by -8.66% in one year.
Market Cap
180.51M
Enterprise Value
95.70M
1-Year Change
-8.66%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $180.51M, a decrease of -49.34%. That is a compound annual growth rate of -14.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 179.23M | -31.88% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 178.03M |
| 2seventy bio | 177.46M |
| The Joint | 177.41M |
| Nanobiotix | 176.93M |
| scPharmaceuticals | 174.14M |
| Galectin Therapeutics | 173.54M |
| Fulcrum Therapeutics | 173.41M |
| Actuate Therapeutics | 172.85M |